Biopharma average M&A deal value by top companies 2010-2019

Select leading companies involved in biopharma merger and acquisition deals worldwide between 2010 and 2019, by average value* (in million U.S. dollars)

Average deal value of biopharma M&A deals worldwide 2010-2019, by top companies

Last update:

Jun 3, 2021

Author:

��ƽ�� Research Department

Region:

Worldwide

Survey time period:

From 01/01/2010 to 31/12/2019

Between 2010 and 2019, the average value for merger and acquisition deals worldwide involving the biopharmaceutical company AbbVie was around 8.15 billion U.S. dollars. This statistic illustrates the average deal value made by select leading biopharma companies in the period 2010-2019.

We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch

�����ƽ��

Select leading companies involved in biopharma merger and acquisition deals worldwide between 2010 and 2019, by average value* (in million U.S. dollars)

Get in touch with us for additional information

��ƽ��